Literature DB >> 26330129

Pneumocystis Jirovecii Pneumonia in Japanese Patients with Rheumatoid Arthritis Treated with Tumor Necrosis Factor Inhibitors: A Pooled Analysis of 3 Agents.

Michi Tanaka, Ryoko Sakai1, Ryuji Koike2, Masayoshi Harigai3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 26330129     DOI： 10.3899/jrheum.141510

Source DB:  PubMed          Journal:  J Rheumatol        ISSN： 0315-162X            Impact factor:   4.666


× No keyword cloud information.
  3 in total

1.  Comparison of the Clinical Characteristics of Pneumocystis Pneumonia between Patients with Rheumatoid Arthritis Being Treated with Biologics and Those Being Treated without Biologics.

Authors:  Mitsuhiro Akiyama; Yuko Kaneko; Tsutomu Takeuchi
Journal:  Biomed Res Int       Date:  2017-07-12       Impact factor: 3.411

2.  Optimal regimens of sulfamethoxazole-trimethoprim for chemoprophylaxis of Pneumocystis pneumonia in patients with systemic rheumatic diseases: results from a non-blinded, randomized controlled trial.

Authors:  Masako Utsunomiya; Hiroaki Dobashi; Toshio Odani; Kazuyoshi Saito; Naoto Yokogawa; Kenji Nagasaka; Kenchi Takenaka; Makoto Soejima; Takahiko Sugihara; Hiroyuki Hagiyama; Shinya Hirata; Kazuo Matsui; Yoshinori Nonomura; Masahiro Kondo; Fumihito Suzuki; Makoto Tomita; Mari Kihara; Waka Yokoyama; Fumio Hirano; Hayato Yamazaki; Ryoko Sakai; Toshihiro Nanki; Ryuji Koike; Hitoshi Kohsaka; Nobuyuki Miyasaka; Masayoshi Harigai
Journal:  Arthritis Res Ther       Date:  2017-01-18       Impact factor: 5.156

Review 3.  Selectivity of Janus Kinase Inhibitors in Rheumatoid Arthritis and Other Immune-Mediated Inflammatory Diseases: Is Expectation the Root of All Headache?

Authors:  Masayoshi Harigai; Suguru Honda
Journal:  Drugs       Date:  2020-08       Impact factor: 9.546
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.